Category | Insight journal

Pharma and biotech clinical stage partnering – recent trends 2009 to 2014

Posted on 02 September 2014

Partnering trends for the top pharma and biotech companies reviewed with over 2,000 deals analyzed – including summary biopharma deal financials

Tags: , , , , ,

Preclinical stage partnering – recent trends 2009 to 2014

Posted on 02 September 2014

Recent trends in preclinical partnering for the top pharma and biotech companies reviewed, over 2,000 deals analyzed – including summary of biopharma deal financials

Tags: , , , ,

Discovery stage in pharma and biotech partnering – Trends from 2009 to 2014

Posted on 02 September 2014

Numerous pharma and biotech partnering deals have been signed at the discovery stage over the past few years; discovery stage deals remain the most popular stage at which deals are announced.

Tags: , , ,

Omega Pharma rumored to be sought after by big pharma companies

Posted on 01 September 2014

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Ingelheim GmbH are rumored to be interested in acquiring the company. 

Tags: , , , , ,

AstraZeneca and Pfizer in the news for another possible m&a bid

Posted on 01 September 2014

AstraZeneca stock rose two percent to £45.67 pounds yesterday after the Swedish newspaper Dagens Industry suggested another possible Pfizer m&a  bid. AstraZeneca stocks have risen 9.5% in the last week, following a stream of good news regarding its pipeline and takeover bids by Pfizer.

Tags: , , ,

M&A rumors for buyout of Achillion Pharmaceuticals by big pharma

Posted on 28 August 2014

UBS analyst Andrew Peters suggested that a recent takeover big in the biotech space of California-based InterMune, Inc.  by Roche was the harbinger of more M&A rumors to come.

Tags: , , ,

Roche drops business merger rumors with Chugai Pharmaceutical

Posted on 27 August 2014

Roche had business merger rumors to buy Tokyo-based Chugai Pharmaceutical Co., Ltd. appear to be tabled for now. Sources in Roche indicated the company was focused on its $8.3 billion acquisition of California-based InterMune Inc.

Tags: , , ,

Is Pfizer’s next acquisition target, Activas?

Posted on 22 August 2014

Bloomberg reports, Pfizer is looking at Actavis, the generics maker with a new home address in Ireland, among other targets.

Tags: , ,

Mylan bids on old drugs of GSK

Posted on 22 August 2014

Several companies, including Mylan , have submitted a second round of bidding for a portfolio of older GlaxoSmithKline drugs.  

Tags: , , , , ,

NPS Pharmaceuticals: Big biotech partnering trends 2009-2014

Posted on 21 August 2014

NPS Pharmaceuticals is a US based specialty company. The company mainly focuses its efforts to treat rare diseases worldwide. 

Tags: ,

cpbannerad300x150new3gif
e56300x150animgif
current-partnering-300x150jpg
RSS Feed Linked In Twitter

Latest Tweets

cabannerad300x150new4gif
2014pharmaci-usabanner300x150gif
current-partnering-300x150-orphanjpg